Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets-Reference-Cited by-同舟云学术

Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets

Published:2013-10 Issue:2 Volume:49 Page:285-290
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Mastroianni Maria Adele,Llohn Abid Hussain,Akkök Çiğdem Akalın,Skogheim Ruby,Ødegaard Elna Rathe,Nybruket Monica Jenssen,Flesland Annika,Mousavi Seyed Ali

Publisher

Elsevier BV

Subject

Hematology

Reference30 articles.

1. Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light;Marschner;Transfus Med Hemother,2011

2. Bacterial contamination of platelets;Palavecino;Transf Apheresis Sci: Off J World Apheresis Assoc: Off J Eur Soc Haemapheresis,2010

3. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress;Perkins;Transfusion,2010

4. Transfusion-transmitted bacterial infection: risks, sources and interventions;Wagner;Vox Sanguinis,2004

5. Clinical relevance of the HLA system in blood transfusion;Brown;Vox Sanguinis,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of mirasol pathogen reduction technology system on immunomodulatory molecules of apheresis platelets;Transfusion and Apheresis Science;2023-02

2. Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review;Seminars in Thrombosis and Hemostasis;2022-10-17

3. Haemostatic profile of riboflavin-treated apheresis platelet concentrates;BLOOD TRANSFUS-ITALY;2022

4. Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic;Transfusion;2021-12-06

5. New strategies for the control of infectious and parasitic diseases in blood donors: the impact of pathogen inactivation methods;The EuroBiotech Journal;2020-04-01